FIELD: pharmaceutics.
SUBSTANCE: present invention relates to derivative of formula (I) or its pharmaceutically acceptable salt, where A: unsubstituted 6-membered aryl or unsubstituted 6-membered heteroaryl containing one nitrogen atom; Y: single bond, -(CH2)p- or -X-; X: -O-, -N(R2)-C(=O)- or -C(=O)-N(R2)-; each L: C1-3 alkylene; R1: unsubstituted C1-6 alkyl; each Z: -N(R2)2; each R2: hydrogen; m equals 0 or 1; n equals 1, 2 or 3; and p is equal to 1. Invention also relates to pharmaceutical composition based on compound of formula (I), method of inhibiting RSV, based on use of compounds of formula (I), method of producing compound of formula (I).
EFFECT: novel benzimidazole derivatives useful as inhibitors of respiratory syncytial virus (RSV).
11 cl, 35 ex
formula (I)
| Title | Year | Author | Number |
|---|---|---|---|
| SPIROINDOLIN COMPOUNDS FOR TREATING AND PREVENTING THE RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2015 |
|
RU2734248C2 |
| NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
| INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES | 2014 |
|
RU2666532C2 |
| SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND USE THEREOF AS INHIBITORS OF UBIQUITIN-SPECIFIC PROCESSING PROTEASE 1 (USP1) | 2019 |
|
RU2833222C2 |
| HETEROCYCLIC COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2667498C2 |
| BICYCLIC LACTAMS AND METHODS OF USE THEREOF | 2016 |
|
RU2827714C1 |
| PHARMACEUTICAL COMPOUNDS | 2020 |
|
RU2840815C2 |
| NOCICEPTIN ANALOGUES | 2002 |
|
RU2426730C2 |
| TRICYCLIC COMPOUNDS PROVIDING DESTRUCTION OF IKAROS PROTEIN AND AIOLOS PROTEIN | 2020 |
|
RU2833608C2 |
| ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
